---
title: Regulatory Affairs | Crystal Bio Solutions
description: Global regulatory strategy, authoring, and eCTD submissions for biologics, ADCs, and CGT—IND/CTA to BLA/MAA across the U.S., EU, and China.
---
-2.png?width=330&height=150&name=Logo_CBS-%E6%A8%AA%E7%89%88-%E5%8E%9F%E8%89%B2(RGB)-2.png)
- [Bioanalysis & Biomarkers](https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers)
- [Characterization & CMC Analytical](https://www.crystalbiosolutions.com/characterization-cmc-analytical)
- [Clinical Pharmacology](https://www.crystalbiosolutions.com/services/clinical-pharmacology)
- [Regulatory Affairs](https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt)
- [Clinical Support](https://www.crystalbiosolutions.com/clinical-research-services)
- [Resources](https://www.crystalbiosolutions.com/news-and-events)
- [About Us](https://www.crystalbiosolutions.com/about-us)
- [Contact Us](https://www.crystalbiosolutions.com/contact-us)
# Regulatory Support for All Stages of Development
With senior regulatory experts across the US, EU, and China, Crystal Bio Solutions functions as an extension of your team. We design global regulatory strategies, author defensible documents, and manage authority interactions to keep your program inspection-ready: from IND/CTA through BLA/MAA, using ICH-aligned best practices and eCTD publishing.
[](https://www.crystalbiosolutions.com/hs/cta/wi/redirect?encryptedPayload=AVxigLKToQD%2BkNxY%2F9GSVP41KKPjLTZbHvgb4URZ3xr5hDeIy%2F2jQBqRSOpdynEHU9pNOJCCHJ4Lx41hOi%2BA6BXfeOy%2BerfFKOn2nVQPHGrVSLVOdbPEkgj%2BG2WGacdwgRjD%2Ba9GFWceKbTg8X5eRYgZYlG7sUER8bsawt8u6wKC%2Bb%2FPePz%2BOCNbWyemDuc3AbaBh9DUsiKixgnKhHeEx11W7CGa2f1O&webInteractiveContentId=264126601418&portalId=146565877&hsLang=en)
Regulatory Strategy End-to-end guidance across development: target product profile and gap assessments, global/bridging plans (FDA/EMA/NMPA), indication and study pathway, comparability for biologics/ADCs, and expedited designations (Fast Track, Breakthrough, RMAT, PRIME) when appropriate. Authoring & Medical Writing Clear, defensible documentation: protocols and IBs, SAPs, CSRs, nonclinical/clinical overviews (CTD Modules 2–5), patient-facing ICFs, briefing packages, and written responses aligned to ICH, GCP, and local guidance. Submission & Approval Submission operations and lifecycle: IND/CTA preparation, eCTD compilation/publishing, QC, query management, variations/supplements, and post-marketing commitments; delivered on schedule and audit-ready.
 Relationships With Authorities We maintain active, structured communication with FDA, EMA, and NMPA on behalf of sponsors. Our team plans meeting strategy, prepares briefing packages and written responses, manages timelines and minutes, and guides query resolution so your development pathway anticipates regulator expectations from pre-IND/Scientific Advice through approval.
**Highlights:**
• Pre-IND/Scientific Advice strategy and questions
• Briefing books, slide decks, and meeting rehearsals
• Written responses, minutes, and follow-ups
• Ongoing query management and risk tracking  Therapeutic Expertise CBS supports complex programs across biologics, ADCs, and CGT while also covering small molecules and 505(b)(2) when needed.
**Modalities & programs:**
• Monoclonal and bispecific antibodies, fusion proteins, biosimilars
• ADCs (clinical experience), radiopharmaceuticals
• Cell & gene therapy programs
• Small molecules and 505(b)(2) applications
## Have a Question?
Connect with our experts and get started on your project today.
[](https://www.crystalbiosolutions.com/hs/cta/wi/redirect?encryptedPayload=AVxigLJJnFAJ7skKmR%2FprpdzyRNQ%2BWo3SvVEXFKbLfrP1k%2B1ykYr1oRs2EJn40FYhaRwih9EP7jz07ze29Pis9ldjMTr%2Fl3xdvW%2BjHGsYidaYUkd7k5AGHXyfleLFS1FAdaOCWGY8AqlD6wM8r9XNkzvh%2FZ09j6meHZMjt0TGANJdgdWUUpXVQl48XW6%2FRaB6nPTlu1ycfBejEF9ji%2F1NsS05QoRNnjr&webInteractiveContentId=270508115133&portalId=146565877&hsLang=en)
- [Our Services](https://www.crystalbiosolutions.com)
- [Bioanalysis and Biomarker](https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers)
- [CMC Analytical](https://www.crystalbiosolutions.com/characterization-cmc-analytical)
- [Clinical Pharmacology](https://www.crystalbiosolutions.com/services/clinical-pharmacology)
- [Regulatory Affairs](https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt)
- [Clinical Support](https://www.crystalbiosolutions.com/clinical-research-services)
- [Information](https://www.crystalbiosolutions.com/news-and-events)
- [Resources](https://www.crystalbiosolutions.com/news-and-events)
- [News & Events](https://www.crystalbiosolutions.com/news-and-events)
- [Careers](https://www.crystalbiosolutions.com/careers-at-crystal-bio-solutions)
- [About us](https://www.crystalbiosolutions.com/about-us)
- [Contact](https://www.crystalbiosolutions.com/contact-us)
- [Email \>](mailto:cbs_bd@crystalpharmatech.com)
- [Contact Form](https://www.crystalbiosolutions.com/contact-us)
- [Our Locations](https://www.crystalbiosolutions.com/locations)
- [Crystal Group \>](https://www.crystalpharmatech.com/)
- [Crystal Pharmatech](https://www.crystalpharmatech.com/)
- [Crystal NAX](https://www.crystalnax.com/)
- [Privacy Policy](https://www.crystalbiosolutions.com/policies/privacy-policy)
- [Terms of Service](https://www.crystalbiosolutions.com/policies/terms-of-service)
Copyright © 2026 Crystal Bio Solutions, All rights reserved
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.crystalbiosolutions.com/#organization",
"@type" : "Organization",
"alternateName" : "CBS",
"contactPoint" : [ {
"@type" : "ContactPoint",
"availableLanguage" : [ "en" ],
"contactType" : "sales",
"email" : "cbs_bd@crystalpharmatech.com",
"url" : "https://www.crystalbiosolutions.com/contact-us"
} ],
"logo" : "https://www.crystalbiosolutions.com/hs-fs/hubfs/CBS%20VI%20v2/CBS%20Logo.png",
"name" : "Crystal Bio Solutions",
"sameAs" : [ "https://www.linkedin.com/company/crystal-bio-solutions/", "https://x.com/crystalbiosol", "https://www.facebook.com/people/Crystal-Bio-Solutions/61579857412775/", "https://www.instagram.com/crystalbiosol/", "https://bsky.app/profile/crystalbiosol.bsky.social" ],
"url" : "https://www.crystalbiosolutions.com/"
}
```
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.crystalbiosolutions.com/#website",
"@type" : "WebSite",
"inLanguage" : "en",
"name" : "Crystal Bio Solutions",
"potentialAction" : {
"@type" : "SearchAction",
"query-input" : "required name=search_term_string",
"target" : "https://www.crystalbiosolutions.com/search?term={search_term_string}"
},
"publisher" : {
"@id" : "https://www.crystalbiosolutions.com/#organization"
},
"url" : "https://www.crystalbiosolutions.com/"
}
```
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt/#webpage",
"@type" : "WebPage",
"about" : {
"@id" : "https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt/#service"
},
"breadcrumb" : {
"@id" : "https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt/#breadcrumb"
},
"description" : "Global regulatory strategy, authoring, and eCTD submissions for biologics, ADCs, and CGT—IND/CTA to BLA/MAA across the U.S., EU, and China.",
"inLanguage" : "en",
"isPartOf" : {
"@id" : "https://www.crystalbiosolutions.com/#website"
},
"name" : "Regulatory Affairs | Crystal Bio Solutions",
"primaryImageOfPage" : {
"@type" : "ImageObject",
"caption" : "Regulatory support for all stages of development",
"url" : "https://www.crystalbiosolutions.com/hs-fs/hubfs/Checking%20a%20medication%20label%20at%20the%20pharmacy.jpg"
},
"url" : "https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt"
}
```
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt/#service",
"@type" : "Service",
"areaServed" : [ "US", "EU", "CN" ],
"audience" : {
"@type" : "Audience",
"audienceType" : [ "Biotech companies", "Pharma companies", "CROs" ]
},
"brand" : {
"@id" : "https://www.crystalbiosolutions.com/#organization"
},
"category" : [ "Global regulatory strategy", "Medical writing and authoring", "eCTD compilation and publishing", "Authority meetings and query management", "Inspection readiness and lifecycle management" ],
"description" : "Global strategy, document authoring, eCTD publishing, and authority interactions from IND/CTA through BLA/MAA; ICH-aligned, inspection-ready outputs.",
"hasOfferCatalog" : {
"@type" : "OfferCatalog",
"itemListElement" : [ {
"@type" : "Offer",
"itemOffered" : {
"@type" : "Service",
"description" : "TPP & gap assessments, FDA/EMA/NMPA planning, indication & pathway, biologics/ADC comparability, expedited designations (Fast Track, Breakthrough, RMAT, PRIME).",
"name" : "Regulatory Strategy"
}
}, {
"@type" : "Offer",
"itemOffered" : {
"@type" : "Service",
"description" : "Protocols, IBs, SAPs, CSRs, CTD Modules 2–5, ICFs, briefing packages, and written responses aligned with ICH/GCP.",
"name" : "Authoring & Medical Writing"
}
}, {
"@type" : "Offer",
"itemOffered" : {
"@type" : "Service",
"description" : "IND/CTA prep, eCTD compilation/publishing, QC, query management, variations/supplements, post-marketing commitments.",
"name" : "Submission & Approval"
}
}, {
"@type" : "Offer",
"itemOffered" : {
"@type" : "Service",
"description" : "Pre-IND/Scientific Advice strategy, briefing books, meeting rehearsals, written responses, minutes, follow-ups, and risk tracking.",
"name" : "Relationships With Authorities"
}
}, {
"@type" : "Offer",
"itemOffered" : {
"@type" : "Service",
"description" : "Biologics, ADCs (incl. radiopharmaceuticals), CGT; also small molecules and 505(b)(2).",
"name" : "Therapeutic Expertise"
}
} ],
"name" : "Regulatory Capabilities"
},
"isRelatedTo" : [ {
"@type" : "Service",
"name" : "Bioanalysis & Biomarkers",
"url" : "https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers"
}, {
"@type" : "Service",
"name" : "CMC Analytical",
"url" : "https://www.crystalbiosolutions.com/characterization-cmc-analytical"
}, {
"@type" : "Service",
"name" : "Clinical Pharmacology",
"url" : "https://www.crystalbiosolutions.com/services/clinical-pharmacology"
}, {
"@type" : "Service",
"name" : "Clinical Support",
"url" : "https://www.crystalbiosolutions.com/clinical-research-services"
} ],
"name" : "Regulatory Affairs",
"provider" : {
"@id" : "https://www.crystalbiosolutions.com/#organization"
},
"serviceOutput" : [ "Briefing packages and written responses", "CTD modules and CSRs", "eCTD submissions", "Inspection-ready documentation" ],
"serviceType" : "Regulatory Affairs for Biologics, ADCs, and CGT",
"url" : "https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt"
}
```
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt/#breadcrumb",
"@type" : "BreadcrumbList",
"itemListElement" : [ {
"@type" : "ListItem",
"item" : "https://www.crystalbiosolutions.com/",
"name" : "Home",
"position" : 1
}, {
"@type" : "ListItem",
"item" : "https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt",
"name" : "Regulatory Affairs",
"position" : 2
} ]
}
```